Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery · 2025
The Application of a Novel Contactless Sleep Monitoring Device in the Diagnosis of Obstructive Sleep Apnea-Hypopnea Syndrome: A Diagnostic Test.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhang Jun, Chen Tengyu, Lv Qiliang, Yang Anni, Xu Yingxiang, Liao Zhenpeng, Chen Xianzhen, Ye Zhongkang, Lai Renjie, Chen Huiting, Hong Haiyu
Аннотация
INTRODUCTION: The polysomnography is inconvenient and complex in diagnosing obstructive sleep apnea-hypopnea syndrome. Diagnostic potency of more novel contactless monitoring devices are needed to be validated to screen individuals with obstructive sleep apnea-hypopnea syndrome. The study aimed to evaluate the diagnostic value of a novel contactless sleep monitoring device in obstructive sleep apnea-hypopnea syndrome.
METHODS: Demographic features and parameters of monitoring devices were collected from adults with suspected obstructive sleep apnea-hypopnea syndrome from September 2023 through March 2024. All participants were monitored with polysomnography and a novel contactless sleep monitoring device simultaneously.
RESULTS: A total of 231 adults with suspected obstructive sleep apnea-hypopnea syndrome were included in the study. In the mild, moderate and severe groups, the accuracy of the novel monitoring device was 96.97%, 85.71% and 85.71%, respectively, with a mean accuracy of 89.36%. The area under the receiver operating characteristic curve of the three groups were 0.9981, 0.9318 and 0.9486, respectively. The sensitivities were 100.00%, 87.50% and 72.00%, respectively. The specificity was 72.00%, 80.95% and 98.32%, respectively. The positive predictive values were 96.71%, 92.45% and 97.59%, respectively. Negative predictive values were 100.00%, 70.83% and 79.05%, respectively. Among 231 subjects, 162 (70.12%) had the same severity classification for both devices. The apnea-hypopnea indexes, total respiratory events and average heart rates were highly correlated between the two devices (p < 0.001).
CONCLUSION: The novel contactless sleep monitoring device is capable of detecting respiratory events during sleep, serving as an effective supplement for preliminary screening of obstructive sleep apnea-hypopnea syndrome.
METHODS: Demographic features and parameters of monitoring devices were collected from adults with suspected obstructive sleep apnea-hypopnea syndrome from September 2023 through March 2024. All participants were monitored with polysomnography and a novel contactless sleep monitoring device simultaneously.
RESULTS: A total of 231 adults with suspected obstructive sleep apnea-hypopnea syndrome were included in the study. In the mild, moderate and severe groups, the accuracy of the novel monitoring device was 96.97%, 85.71% and 85.71%, respectively, with a mean accuracy of 89.36%. The area under the receiver operating characteristic curve of the three groups were 0.9981, 0.9318 and 0.9486, respectively. The sensitivities were 100.00%, 87.50% and 72.00%, respectively. The specificity was 72.00%, 80.95% and 98.32%, respectively. The positive predictive values were 96.71%, 92.45% and 97.59%, respectively. Negative predictive values were 100.00%, 70.83% and 79.05%, respectively. Among 231 subjects, 162 (70.12%) had the same severity classification for both devices. The apnea-hypopnea indexes, total respiratory events and average heart rates were highly correlated between the two devices (p < 0.001).
CONCLUSION: The novel contactless sleep monitoring device is capable of detecting respiratory events during sleep, serving as an effective supplement for preliminary screening of obstructive sleep apnea-hypopnea syndrome.